Company News

Cambridge, UK, 30th April 2018 / Domainex Ltd, a privately-owned drug discovery services company, is proud to announce its inclusion in the second annual top 1000 list of Europe’s fastest growing companies, published by the Financial Times.  The
Cambridge, UK, 12th March 2018 / Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce the appointment of Dr Bodo Spori as Head of Business Development for Europe.
Cambridge, UK, 1st February 2018 / Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce that Dr Kevin Doyle has been appointed Head of Chemistry with immediate effect.  His appointment strengthens the expanding team of in
Cambridge, UK, 6th December 2017 / Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce that Chris Brown has been appointed Chief Financial Officer with immediate effect.
Domainex, a drug discovery services company, is pleased to announce that Dr Timo Veromaa has been appointed Executive Chairman with immediate effect.
Domainex launched its fragment screening service, FragmentBuilder, and is the first CRO in the UK to offer MicroScale Thermophoresis (MST) as part of drug discovery services.
Sir Simon Campbell opened the Domainex Medicines Research Centre, which will double the laboratory space available to the company’s growing team of scientists.
11th November 2016
Domainex will hold an opening ceremony on 11th November to mark their relocation to Chesterford Research Park.
To support the company’s growth in drug research services, Domainex is moving to the Churchill Building of Chesterford Research Park.

Pages